CSF1R and COVID-19: Rediscovery of the CSF1R as a reproducible lineage biomarker of mononuclear phagocytes in human blood opens the door to integrated studies of innate and adaptive immunity in health and disease, patient stratification in the clinic, and future anti-inflammatory therapies for COVID-19 and other infections or malignant diseases.